What Does CGM Stand for: How It Works, Accuracy, and When

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • CGM stands for continuous glucose monitor, a wearable sensor that measures interstitial glucose every one to five minutes.
  • Modern CGMs are accurate enough that the FDA has cleared several for insulin dosing without a confirmatory fingerstick.
  • CGMs benefit people with type 1 and insulin-using type 2 diabetes most, with growing evidence for prediabetes and non-insulin users.
  • Sensors last 7 to 15 days depending on the model and report readings to a smartphone, reader, or insulin pump.
  • Talk with your clinician about whether a CGM fits your goals before purchasing out of pocket.

CGM stands for continuous glucose monitor, a wearable sensor that measures glucose in the fluid just under your skin every one to five minutes. Unlike a fingerstick meter that captures a single point in time, a CGM builds a trend line across hours and days. This helps people with diabetes, prediabetes, and some athletes understand how food, activity, sleep, and stress move their blood sugar.

What Does CGM Stand for in Diabetes Care

CGM is short for continuous glucose monitor (sometimes continuous glucose monitoring, referring to the practice rather than the device). The term covers any wearable system that uses a subcutaneous sensor wire and a small transmitter to stream glucose readings to a receiver, smartphone, or insulin pump. Examples include Dexcom G6 and G7, Abbott FreeStyle Libre 2 and 3, Medtronic Guardian Connect, and Senseonics Eversense.

The American Diabetes Association’s 2024 Standards of Care recommend CGM for all adults and youth with type 1 diabetes, and increasingly for people with insulin-treated type 2 diabetes. A growing body of research also supports short-term use for people with type 2 who are not on insulin, and for those with prediabetes who want data on how meals affect them.

How a CGM Works Under the Skin

A CGM sensor is about the size of a small coin or a quarter-inch disc with a tiny flexible filament beneath it. The filament sits in interstitial fluid, the watery tissue between cells, where glucose equilibrates a few minutes behind the bloodstream. A glucose-oxidase enzyme on the filament produces a small electrical signal proportional to glucose concentration. The transmitter converts that signal into a reading and sends it via Bluetooth to your smartphone.

Key Parts of a Modern CGM

  • Sensor: the disposable patch with the subcutaneous filament.
  • Transmitter: built into the sensor in Libre and G7, separate in older Dexcom models.
  • Receiver or app: displays the reading, trend arrow, and alerts.
  • Cloud service: lets caregivers and clinicians see data remotely (Dexcom Share, LibreView).

How Accurate Is a CGM?

CGM accuracy is often reported as mean absolute relative difference (MARD), a comparison between sensor readings and lab glucose. Lower is better. Current leading sensors have MARD around 8 to 10 percent in adults:

Device Sensor Life Adult MARD (%) Fingerstick Needed?
Dexcom G7 10 days ~8.2 No (iCGM cleared)
FreeStyle Libre 3 Plus 15 days ~7.8 No (iCGM cleared)
Dexcom Stelo (OTC) 15 days ~10.0 No for non-insulin users
Senseonics Eversense 365 365 days ~8.5 Twice daily calibration

For context, a typical home fingerstick meter has a MARD of 5 to 10 percent against lab reference. That means modern CGMs are accurate enough for insulin dosing when the FDA has granted integrated CGM (iCGM) clearance. Early CGMs required two daily calibrating fingersticks; most current sensors are factory calibrated.

Who Benefits Most from a CGM?

  • Type 1 diabetes: strongest evidence; CGM reduces A1C and hypoglycemia.
  • Insulin-using type 2 diabetes: robust clinical trial benefit.
  • Non-insulin type 2 and prediabetes: growing use for education and behavior change.
  • Gestational diabetes and pregnancy: helpful for tight targets.
  • Athletes and biohackers: personal education; no clinical mandate.

If your focus is on understanding A1C levels and how specific meals affect you, a two-week CGM trial can be more informative than months of random fingersticks.

When a CGM Beats Fingerstick Testing

A CGM shows direction of change, not just a number. The trend arrow tells you whether glucose is rising, falling, or flat, which a fingerstick cannot. That is especially useful overnight, during exercise, and after meals. CGMs also log data automatically, so there is no notebook to keep. Many platforms generate an ambulatory glucose profile (AGP) report that clinicians can review at appointments.

However, fingersticks still have a role. If a CGM reading does not match how you feel, confirm with a fingerstick. Some drugs and supplements can interfere with sensor chemistry; Dexcom G7, for example, lists high-dose acetaminophen as a possible interference on older models. Always read your device’s user guide.

How to Get Started

Most people get a CGM through their clinician. Bring a recent A1C, medication list, and goals to the appointment. Ask:

  • Which CGM is preferred by my insurance?
  • What alerts should I set for high and low glucose?
  • How often will we review data?

Pair the device with any habits you are already building through our diet and nutrition hub so the data drives specific changes rather than anxiety.

The Bottom Line

CGM stands for continuous glucose monitor, a small wearable sensor that measures glucose every few minutes and streams the data to your phone. Modern CGMs are accurate enough for insulin decisions, can replace most fingersticks, and give you a trend-based view of glucose that a meter cannot match. Talk with your clinician about whether a prescription CGM or the new over-the-counter Stelo fits your situation.

Medical disclaimer: This article is educational and is not medical advice. Consult your healthcare provider before starting or stopping any glucose monitoring device.

Frequently Asked Questions

What does CGM mean in diabetes?

CGM means continuous glucose monitor. It is a small wearable sensor, usually on the back of the upper arm or abdomen, that measures glucose in the fluid under the skin every one to five minutes. Readings stream wirelessly to a smartphone app, a dedicated reader, or an insulin pump. This gives a near-real-time picture of glucose trends.

How accurate is a CGM compared with a fingerstick?

Modern CGMs have mean absolute relative differences around 8 to 10 percent compared with lab glucose, which is close to the accuracy of many home fingerstick meters. The FDA has cleared several CGMs, including Dexcom G7 and FreeStyle Libre 3 Plus, for use without routine confirmatory fingersticks, though fingersticks are still recommended if readings do not match symptoms.

Do you need a prescription for a CGM?

In the United States, yes. All currently marketed medical CGMs, including Dexcom, FreeStyle Libre, and Stelo, were historically prescription-only. The FDA cleared the Dexcom Stelo in 2024 as the first over-the-counter CGM for non-insulin users. Other sensors still require a clinician prescription.

How long does a CGM sensor last?

Sensor life depends on the model. FreeStyle Libre 2 Plus and Libre 3 last 15 days. Dexcom G6 lasts 10 days. Dexcom G7 and Stelo last 10 and 15 days respectively. Implanted sensors like Eversense last up to a year. After the wear time, you replace the sensor with a new one.

Can a CGM replace a finger prick meter entirely?

For many users, yes. FDA-cleared CGMs can be used to make diabetes decisions without routine fingersticks. However, keep a backup meter for situations where readings do not match how you feel, during the first few hours after sensor insertion, or when using certain medications like high-dose acetaminophen that may affect some sensors.

Sources

  1. American Diabetes Association, Standards of Care 2024, Chapter 7 Diabetes Technology, https://diabetesjournals.org/care/article/47/Supplement_1/S126/153955
  2. U.S. Food and Drug Administration, Blood Glucose Monitoring Devices, https://www.fda.gov/medical-devices/in-vitro-diagnostics/blood-glucose-monitoring-devices
  3. National Institute of Diabetes and Digestive and Kidney Diseases, Continuous Glucose Monitoring, https://www.niddk.nih.gov/health-information/diabetes/overview/managing-diabetes/continuous-glucose-monitoring